Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Takeda to Divest TachoSil® to Corza Health for €350 Million
OSAKA, JAPAN, September 16, 2020 – Takeda Pharmaceutical Company Limited (TSE.
Kodak execs didn't illegally trade stock while touting big move into pharma: report
Eastman Kodak's pharma ambitions took a hit when insider trading accusations put $765 million in U.
Germany grants BioNTech, CureVac $745 million to speed up COVID-19 vaccine work
BERLIN (Reuters) - Germany awarded $745 million in funding to biotech firms BioNTech and CureVac on Tuesday to speed up work on COVID-19 vaccines and expand German production capacity.
Some volunteers quit J&J COVID-19 trial in Spain after AstraZeneca scare: investigator
MADRID (Reuters) - Some volunteers have quit Johnson & Johnson’s COVID-19 vaccine trial in Spain after news of side effects in a participant in AstraZeneca’s trial, the Spanish program...
EU to build biomedical agency, convene health summit, says Von der Leyen
BRUSSELS (Reuters) - The European Union will build its own agency for biomedical research and convene a global health summit in Italy next year in a bid to be better prepared for future pandem...
Painless paper patch test for glucose levels uses microneedles
Tokyo, Japan -- Patches seem to be all the rage these days.
U.S. appeals court revives New York tax on opioid companies
(Reuters) - A federal appeals court on Monday cleared the way for New York state to collect about $200 million from drug manufacturers and distributors by imposing a surcharge on them to defra...
Takeda opens new R&D manufacturing facility for cell therapies
Takeda Pharmaceutical has opened a new R&D manufacturing facility for cell therapies at Boston, Massachusetts, US, the company's R&D headquarters.
Baricitinib in Combination with Remdesivir Reduces Time to Recovery in Hospitalized Patients with COVID-19 in NIAID-Sponsored ACTT-2 Trial
INDIANAPOLIS, Sept.
China coronavirus vaccine may be ready for public in November: official
BEIJING (Reuters) - Coronavirus vaccines being developed in China may be ready for use by the general public as early as November, an official with the Chinese Center for Disease Control and P...
RECOVERY COVID-19 phase 3 trial to evaluate Regeneron’s REGN-COV2 investigational antibody cocktail in the UK
One of the world’s largest efforts to find effective COVID-19 treatments will evaluate the impact of REGN-COV2 on mortality, hospital stays, and the need for ventilation.
The UAE has approved a Chinese-made coronavirus vaccine for emergency use
The vaccine, developed by China’s Sinopham, will be given to the UAE’s frontline workers.
306
307
308
309
310
311
312
313
314
